147 related articles for article (PubMed ID: 1973114)
1. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals.
Duteil J; Rambert FA; Pessonnier J; Hermant JF; Gombert R; Assous E
Eur J Pharmacol; 1990 May; 180(1):49-58. PubMed ID: 1973114
[TBL] [Abstract][Full Text] [Related]
2. Awakening properties of modafinil: effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration.
Hermant JF; Rambert FA; Duteil J
Psychopharmacology (Berl); 1991; 103(1):28-32. PubMed ID: 1672457
[TBL] [Abstract][Full Text] [Related]
3. Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice.
Simon P; Hémet C; Ramassamy C; Costentin J
Eur Neuropsychopharmacol; 1995 Dec; 5(4):509-14. PubMed ID: 8998404
[TBL] [Abstract][Full Text] [Related]
4. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.
Lin JS; Roussel B; Akaoka H; Fort P; Debilly G; Jouvet M
Brain Res; 1992 Sep; 591(2):319-26. PubMed ID: 1359924
[TBL] [Abstract][Full Text] [Related]
5. Preliminary studies on the structure-activity and time-effect relations of the central stimulating effects of modafinil in mice.
Zhan H; Tang GX; Xin YM; Li YF; Li T; Wei ShH; Mu BC; Lei GQ
Space Med Med Eng (Beijing); 2004 Feb; 17(1):12-5. PubMed ID: 15005110
[TBL] [Abstract][Full Text] [Related]
6. Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission.
Sebban C; Zhang XQ; Tesolin-Decros B; Millan MJ; Spedding M
Br J Pharmacol; 1999 Nov; 128(5):1045-54. PubMed ID: 10556942
[TBL] [Abstract][Full Text] [Related]
7. Behavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action.
Mitchell HA; Bogenpohl JW; Liles LC; Epstein MP; Bozyczko-Coyne D; Williams M; Weinshenker D
Pharmacol Biochem Behav; 2008 Dec; 91(2):217-22. PubMed ID: 18703079
[TBL] [Abstract][Full Text] [Related]
8. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
9. Effect of modafinil on pancreatic exocrine secretion in the rat. A comparison with methadone.
Nagain C; Chariot J; Vaille C; Rozé C
Eur J Pharmacol; 1991 Aug; 201(2-3):203-8. PubMed ID: 1686759
[TBL] [Abstract][Full Text] [Related]
10. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
Haapalinna A; Leino T; Heinonen E
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451
[TBL] [Abstract][Full Text] [Related]
11. Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats.
Ishizuka T; Murakami M; Yamatodani A
Eur J Pharmacol; 2008 Jan; 578(2-3):209-15. PubMed ID: 17920581
[TBL] [Abstract][Full Text] [Related]
12. [Effect of modafinil on electroretinograms of Lycosa tarentula in relation visual circadian rhythm (Araneae, Lycosidae)].
Carricaburu P; Muñoz-Cuevas A
C R Seances Soc Biol Fil; 1998; 192(6):1163-73. PubMed ID: 10101611
[TBL] [Abstract][Full Text] [Related]
13. [A unique psychopharmacologic profile of adrafinil in mice].
Rambert FA; Pessonnier J; de Sereville JE; Pointeau AM; Duteil J
J Pharmacol; 1986; 17(1):37-52. PubMed ID: 3713198
[TBL] [Abstract][Full Text] [Related]
14. Analysis of stimulant locomotor effects of modafinil in various strains of mice and rats.
Simon P; Hémet C; Costentin J
Fundam Clin Pharmacol; 1996; 10(5):431-5. PubMed ID: 8902545
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.
Uguen M; Perrin D; Belliard S; Ligneau X; Beardsley PM; Lecomte JM; Schwartz JC
Br J Pharmacol; 2013 Jun; 169(3):632-44. PubMed ID: 23472741
[TBL] [Abstract][Full Text] [Related]
16. Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats.
Rowley HL; Kulkarni RS; Gosden J; Brammer RJ; Hackett D; Heal DJ
J Psychopharmacol; 2014 Mar; 28(3):254-69. PubMed ID: 24327450
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and cross sensitization after repeated exposure to modafinil and apomorphine in rats.
Chang ST; Tung CS; Lin YL; Chuang CH; Lee AR; Liu YP
Chin J Physiol; 2010 Oct; 53(5):318-27. PubMed ID: 21793343
[TBL] [Abstract][Full Text] [Related]
18. Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
Srinivasan J; Schmidt WJ
J Neural Transm (Vienna); 2005 Sep; 112(9):1223-36. PubMed ID: 15614426
[TBL] [Abstract][Full Text] [Related]
19. The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine.
Simon P; Panissaud C; Costentin J
Psychopharmacology (Berl); 1994 May; 114(4):597-600. PubMed ID: 7855221
[TBL] [Abstract][Full Text] [Related]
20. Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG.
Chapotot F; Pigeau R; Canini F; Bourdon L; Buguet A
Psychopharmacology (Berl); 2003 Mar; 166(2):127-38. PubMed ID: 12552359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
